Huabang Health: 2024 Semi-Annual Financial Report
Huabang Health: Half-year summary table of non-operating capital usage and other related capital transactions
Huapont Life Sciences: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Huapont Life Sciences: 2023 Annual General Meeting of Shareholders Legal Opinions
Huapont Life Sciences: Announcement on preparing to accrue asset impairment
Huapont Life Sciences: Announcement on holding an online briefing on the 2023 annual results
Huapont Life Sciences: 2023 Financial Results Report
Huapont Life Sciences: Summary table on the use of non-operating capital and other related capital transactions in 2023
Huapont Life Sciences: Report on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties by the Audit Committee
Huapont Life Sciences: Notice of Annual General Meeting of Shareholders
Huapont Life Sciences: Internal Control Self-Assessment Report
Huabang Health: Notice on Using Temporarily Idle Own Funds for Cash Management
Huabang Health: Legal Opinion of the First Extraordinary General Meeting of Shareholders in 2023
Huabang Health: Announcement of Resolutions of the First Extraordinary General Meeting of Shareholders in 2023
Huabang Health: Announcement on the issuance results of convertible corporate bonds issued to unspecified targets by Shandong Kaisheng New Materials Co., Ltd., a holding subsidiary
Huabang Health: Board of Directors Meeting Rules of Procedure (December 2023)
Huabang Health: Board Remuneration and Assessment Committee Work Rules (December 2023)
Huabang Health: Announcement on the anticipated launch of forward foreign exchange settlement business and RMB to foreign exchange options portfolio business in 2024
Huabang Health: Rules of Work of the Board Strategy Committee (December 2023)
Huabang Health: Working Rules of the Audit Committee of the Board of Directors (December 2023)
No Data
No Data